The role of ATM as a risk factor for breast cancer has been discussed for nearly 20 years, and the estimated relative risk is 1.3 to 12.7.82 Renwick et al83 reported ATM mutations in 12 of 441 breast cancer cases with BRCA1/BRCA2-negative mutations. This evidence concerns the gene BRCA1 and breast carcinoma.